NextCure
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -283 | -365 | ||
EBITDA | -14,892 | -9,513 | -9,071 | -8,091 |
EBIT | -9,796 | -9,436 | -8,624 | |
Net Income | -14,892 | -9,796 | -9,436 | -8,624 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -9,715 | -13,363 | -7,638 | -6,268 |
Cash | 15,260 | 15,167 | 25,982 | 7,324 |
Basic Shares | 5,309 | 5,239 | 3,505 | 2,676 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -2,185 | -2,865 | -3,684 | -4,480 |
EBITDA | -53,659 | -54,341 | -59,039 | -71,785 |
EBIT | -55,844 | -57,206 | -62,723 | -75,909 |
Net Income | -55,844 | -55,654 | -62,723 | -69,433 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 14,293 | |||
Free Cash Flow | -49,613 | -41,279 | -53,794 | -56,002 |
Cash | 25,982 | 27,727 | 13,082 | 26,630 |
Basic Shares | 2,842 | 2,330 | 2,319 | 2,312 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$1.84 |
2026-03-31 | -$1.87 |
2025-12-31 | -$0.81 |
2025-09-30 | -$3.22 |